🇺🇸 Grazoprevir/Elbasvir in United States

70 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Hepatitis C — 26 reports (37.14%)
  2. Treatment Failure — 20 reports (28.57%)
  3. Virologic Failure — 6 reports (8.57%)
  4. Therapy Non-Responder — 5 reports (7.14%)
  5. Atrial Fibrillation — 3 reports (4.29%)
  6. Death — 2 reports (2.86%)
  7. Drug Interaction — 2 reports (2.86%)
  8. Hepatocellular Carcinoma — 2 reports (2.86%)
  9. Pathogen Resistance — 2 reports (2.86%)
  10. Rash — 2 reports (2.86%)

Source database →

Other Infectious Disease / Virology approved in United States

Frequently asked questions

Is Grazoprevir/Elbasvir approved in United States?

Grazoprevir/Elbasvir does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Grazoprevir/Elbasvir in United States?

Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba is the originator. The local marketing authorisation holder may differ — check the official source linked above.